| |
OR (95% CI)
adjusted for age and gender
|
Sensitivity
|
Specificity
|
PPV
|
NPV
|
|---|
|
Leiden EARC
| | | | | |
|
≥30 minutes
|
1.24 (0.89-1.73)
|
31.9%
|
72.1%
|
49.5%
|
55.2%
|
|
≥60 minutes
|
1.49 (1.001-2.20)
|
21.2%
|
84.2%
|
53.5%
|
55.5%
|
|
≥90 minutes
|
1.98 (1.18-3.30)
|
13.5%
|
92.9%
|
62.0%
|
55.6%
|
|
Groningen EARC
| | | | | |
|
≥30 minutes
|
1.63 (1.07-2.47)
|
40.3%
|
70.0%
|
62.3%
|
48.7%
|
|
≥60 minutes
|
2.21 (1.33-3.69)
|
27.0%
|
85.3%
|
69.3%
|
48.6%
|
|
≥90 minutes
|
2.16 (1.14-4.10)
|
16.8%
|
91.8%
|
71.7%
|
47.2%
|
|
REACH
| | | | | |
|
≥30 minutes
|
1.07 (0.69-1.65)
|
54.4%
|
48.2%
|
53.0%
|
50.3%
|
|
≥60 minutes
|
1.55 (0.97-2.47)
|
37.8%
|
72.6%
|
59.7%
|
47.9%
|
|
≥90 minutes
|
2.05 (1.18-3.58)
|
26.7%
|
85.1%
|
65.8%
|
48.0%
|
- OR, odds ratio; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; EARC, Early Arthritis Recognition Clinic; REACH, Rotterdam Early Arthritis Cohort.
